In an in vitro co-culture assay, we further confirmed that HMGB2-deficient NK cells showed enhanced killing ability on a variety of ESCC cell lines, especially in poorly differentiated tumor cells such as KYSE70 and KYSE150. The gene discussed is HMGB2; the disease is neoplasm.